Complement activation profile of patients with primary focal segmental glomerulosclerosis

Clinical Significance of IgM and C3 Glomerular Deposition in Primary Focal Segmental Glomerulosclerosis

(2016) Y.-m. Zhang et al.   Clinical Journal of the American Society of Nephrology

Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS

(2015) R. Cofiell et al.   BLOOD

IgM exacerbates glomerular disease progression in complement-induced glomerulopathy

(2015) Sarah E. Panzer et al.   KIDNEY INTERNATIONAL

Complement Activation in Patients with Focal Segmental Glomerulosclerosis

(2015) Joshua M. Thurman et al.   PLoS One

Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis

(2014) Jing Huang et al.   BMC Medicine

How antibodies use complement to regulate antibody responses

(2014) Anna Sörman et al.   MOLECULAR IMMUNOLOGY

Treatment of C3 Glomerulopathy with Complement Blockers

(2014) Francesco Emma et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

IgM Contributes to Glomerular Injury in FSGS

(2013) D. Strassheim et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Novel roles of complement in renal diseases and their therapeutic consequences

(2013) Takehiko Wada et al.   KIDNEY INTERNATIONAL

Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis

(2013) Jing Huang et al.   KIDNEY INTERNATIONAL

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

(2011) Changli Wei et al.   NATURE MEDICINE

Focal Segmental Glomerulosclerosis

(2011) Vivette D. D'Agati et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system

(2010) Feng Yu et al.   KIDNEY INTERNATIONAL